Perceptive Advisors’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,500,000
Closed -$19.7M 163
2020
Q4
$19.7M Hold
2,500,000
0.21% 85
2020
Q3
$21.2M Buy
+2,500,000
New +$27.4M 0.31% 67
2019
Q1
Sell
-59,498
Closed -$2.5M 122
2018
Q4
$2.5M Sell
59,498
-174,521
-75% -$7.76M 0.1% 72
2018
Q3
$11.7M Sell
234,019
-48,779
-17% -$2.2M 0.31% 53
2018
Q2
$10.8M Sell
282,798
-180,000
-39% -$7.75M 0.28% 58
2018
Q1
$18.6M Sell
462,798
-200,000
-30% -$8.41M 0.52% 48
2017
Q4
$23.3M Buy
662,798
+20,000
+3% +$583K 0.77% 35
2017
Q3
$14M Sell
642,798
-20,000
-3% -$402K 0.53% 46
2017
Q2
$12.3M Sell
662,798
-2,400
-0.4% -$51.7K 0.62% 45
2017
Q1
$18.3M Hold
665,198
1.04% 30
2016
Q4
$18.1M Sell
665,198
-18,250
-3% -$594K 1.29% 21
2016
Q3
$22.2M Buy
683,448
+160,853
+31% +$3.8M 1.43% 12
2016
Q2
$10.8M Buy
522,595
+346,595
+197% +$5.4M 0.75% 30
2016
Q1
$2.44M Buy
+176,000
New +$2.46M 0.21% 81

Other funds holding WVE

Perceptive Advisors's WVE Position: Q1 2021 in Review

Perceptive Advisors sold out of Wave Life Sciences (WVE) in Q1 2021, closing a stake of 2,500,000 shares — an estimated $19.7M sold.

Perceptive Advisors first reported a position in WVE in Q1 2016 and held it in 14 quarters. The position peaked at $23.3M in Q4 2017. 102 funds tracked by Wall St. Rank hold WVE as of Q1 2021.

  • Perceptive Advisors reported no remaining Wave Life Sciences position as of Q1 2021 after selling out during the quarter.
  • Perceptive Advisors sold 2,500,000 Wave Life Sciences shares in Q1 2021, an estimated $19.7M.
  • Perceptive Advisors first reported a position in Wave Life Sciences in Q1 2016 and held it in 14 quarters.
  • Perceptive Advisors's Wave Life Sciences position peaked at $23.3M in Q4 2017.
  • 102 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2021.

Based on Perceptive Advisors's 13F filing for Q1 2021, filed 17 May 2021.